Carnitine and coenzyme A are cofactors in cellular intermediary metabolism. Multiple disease states are associated with cellular acyl-CoA accumulation which interferes with short-term metabolic regulation. The current proposal is designed to test the hypothesis that the status of the coenzyme A pool is a key factor in the long-term regulation of cellular energy homeostasis. Specifically, it is hypothesized that 1) cellular coenzyme A content is regulated via both biosynthesis and degradation based on the coenzyme A and acyl-CoA contents in the cytosol and mitochondria, and 2) the status of the coenzyme A pool, either directly or through secondary metabolic alterations, contributes to the regulation of cellular mitochondrial content. Hydroxycobalamin[c-lactam) (HCCL) treatment in rats has been developed as a facile model of acyl-CoA buildup secondary to decreased L-methylmalonyl CoA mutase activity. Studies will be performed to characterize the regulation of coenzyme A biosynthesis, degradation, and subcellular distribution in response to acyl-CoA accretion. The acute effects of acyl-CoA accumulation on redistribution of cellular CoA between the cytosolic and mitochondrial compartments will be defined and the consequences of this redistribution on coenzyme A homeostasis assessed. A feature of HCCL treatment is an increased hepatic mitochondrial content. mtDNA content and levels of mitochondrial mRNAs will be quantified in liver from control and HCCL-treated rats. Using isolated mitochondria and in vitro cell culture, kinetics of mitochondrial protein synthesis will be quantified in the absence and presence of HCCL treatment. Early molecular events in the initiation of mitochondrial proliferation will be identified and used to define the metabolic conditions required for the enhanced mitochondrial content. Acyl-CoA accumulation will be induced acutely and the initiation of mitochondrial proliferation monitored. Previous work has identified decreased cytochrome b content in mitochondria from HCCL-treated rats. Formation, processing and translation of cytochrome b mRNA will be quantified to define the basis for the HCCL-induced complex III defect. The current proposal thus utilizes a well-defined model of metabolic disease to define the metabolic regulation of cellular mitochondrial and coenzyme A homeostasis. The project will provide new insights into the cellular mechanism of disease, will contribute to the development of new therapeutic strategies, and will provide information on the fundamental cell biology of mitochondria.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK036069-09
Application #
2139711
Study Section
Medical Biochemistry Study Section (MEDB)
Project Start
1985-09-23
Project End
1997-06-30
Budget Start
1994-09-30
Budget End
1995-06-30
Support Year
9
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Lesnefsky, Edward J; He, DingChao; Moghaddas, Shadi et al. (2006) Reversal of mitochondrial defects before ischemia protects the aged heart. FASEB J 20:1543-5
Lesnefsky, E J; Gudz, T I; Moghaddas, S et al. (2001) Aging decreases electron transport complex III activity in heart interfibrillar mitochondria by alteration of the cytochrome c binding site. J Mol Cell Cardiol 33:37-47
Lesnefsky, E J; Gudz, T I; Migita, C T et al. (2001) Ischemic injury to mitochondrial electron transport in the aging heart: damage to the iron-sulfur protein subunit of electron transport complex III. Arch Biochem Biophys 385:117-28
Weinberg, G L; Palmer, J W; VadeBoncouer, T R et al. (2000) Bupivacaine inhibits acylcarnitine exchange in cardiac mitochondria. Anesthesiology 92:523-8
Lesnefsky, E J; Stoll, M S; Minkler, P E et al. (2000) Separation and quantitation of phospholipids and lysophospholipids by high-performance liquid chromatography. Anal Biochem 285:246-54
Fannin, S W; Lesnefsky, E J; Slabe, T J et al. (1999) Aging selectively decreases oxidative capacity in rat heart interfibrillar mitochondria. Arch Biochem Biophys 372:399-407
Lesnefsky, E J; Tandler, B; Ye, J et al. (1997) Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria. Am J Physiol 273:H1544-54